Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

IP Litigation

Law360: Has Amgen Already Won Its BPCIA Dispute With Sandoz?

August 3, 2017

IP Litigation

Law360: Has Amgen Already Won Its BPCIA Dispute With Sandoz?

August 3, 2017

Back to Fish's Litigation Blog

 

By: Ron Vogel and Brian Coggio

Fish attorneys Brian Coggio and Ron Vogel recently published an article in Law360 where they discuss the Supreme Court determination “that Sandoz ‘violated’ the Biologics Price Competition and Innovation Act by failing to disclose its confidential information to Amgen. And according to the court, this violation is “unlawful” under California unfair competition law. Accordingly, has the disclosure issue been resolved?”

To read the full article, visit Law360.

Related Tags

Amgen v. Sandoz
Law360

Blog Authors

Headshot
Brian D. Coggio | Of Counsel

Mr. Coggio is Of Counsel to the New York office of Fish & Richardson. He has extensive law firm experience as a senior trial attorney and counselor and has litigated disputes across a wide range of technologies with a particular focus in chemical, pharmaceutical, medical device,...

Headshot
Ron Vogel | Associate

Ron Vogel is a litigation Associate in the New York office of Fish & Richardson.  His life sciences practice involves litigation, licensing, and counseling services in the biotechnology, pharmaceuticals, and medical devices fields.  His regulatory practice focuses on FDA work,...

Leave a Reply

Your email address will not be published. Required fields are marked *

Protected with IP Blacklist CloudIP Blacklist Cloud